Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the latest release of Cardiovascular Workspace (IntelliSpace Cardiovascular, ISCV).
Philips Cardiovascular Workspace on HealthSuite now has cloud-hosted availability and software-as-a-service (SaaS) deployment. It aims to help health systems speed up AI adoption and automate analysis, documentation, and reporting.
The company said the workspace provides the foundation for future AI-enabled tools and workflow insights across cardiology care and enables secure remote reading while improving efficiency.
The latest release expands Philips' collaboration with Amazon Web Services (AWS) to bring integrated diagnostics to the cloud, it said.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
